MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4

Figure 1 The expression of miR-630 in diabetic kidney disease rats. A: Differential expression of miR-630, renal weight index, and blood glucose in diabetic kidney disease rats; B: The correlations between the expression of miR-630 and clinical parameters, including body weight, serum albumin, renal weight index, blood urea nitrogen, serum creatinine and proteinuria, were analysed by Pearson correlation analysis and linear regression analysis; C: Pathological changes in renal tissue in rats under a high glucose environment (hematoxylin and eosin, × 400). n = 15. Data are presented as mean ± SD, ^aP < 0.001, ^bP < 0.001, ^cP < 0.001, ^dP < 0.001. DKD: Diabetic kidney disease.